6541.TW
Price:
$61.3
Market Cap:
$16.23B
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar in Taiwan and the United States. The company focuses on delivering biosimilars which target neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. Its products pipeline includes TX01 and TX-05 which have completed Phase III clinical trials; TX-04 and TX-16 that are in Phase I clinical trial; and TX-52 and other products which are in pre-clinical trial. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands.
Industry
Biotechnology
IPO Date
2015-08-13
Stock Exchange
TAI
Ticker
6541.TW
According to Tanvex BioPharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.97. This represents a change of 19.03% compared to the average of 2.49 of the last 4 quarters.
The mean historical Current Ratio of Tanvex BioPharma, Inc. over the last ten years is 9.00. The current 2.97 Current Ratio has changed 3.20% with respect to the historical average. Over the past ten years (40 quarters), 6541.TW's Current Ratio was at its highest in in the September 2016 quarter at 37.01. The Current Ratio was at its lowest in in the March 2016 quarter at 0.
Average
9.00
Median
8.63
Minimum
1.66
Maximum
19.28
Discovering the peaks and valleys of Tanvex BioPharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 66.20%
Maximum Annual Current Ratio = 19.28
Minimum Annual Increase = -64.39%
Minimum Annual Current Ratio = 1.66
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 1.94 | 16.83% |
| 2023 | 1.66 | -51.73% |
| 2022 | 3.44 | -64.39% |
| 2021 | 9.67 | 50.78% |
| 2020 | 6.41 | -33.45% |
| 2019 | 9.63 | -45.42% |
| 2018 | 17.65 | -8.49% |
| 2017 | 19.28 | 52.24% |
| 2016 | 12.67 | 66.20% |
| 2015 | 7.62 | 56.59% |
The current Current Ratio of Tanvex BioPharma, Inc. (6541.TW) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.35
5-year avg
4.62
10-year avg
9.00
Tanvex BioPharma, Inc.’s Current Ratio is greater than Ever Supreme Bio Technology Co., Ltd (1.69), less than Foresee Pharmaceuticals Co., Ltd. (3.67), less than Medigen Vaccine Biologics Corporation (14.12), greater than Excelsior Medical Co., Ltd. (1.63), less than AP Biosciences Inc (49.57), less than YungShin Global Holding Corporation (3.66), less than PharmaEngine, Inc. (43.53), less than Acepodia, Inc. (39.46), less than EirGenix Inc. (7.56), less than ScinoPharm Taiwan, Ltd. (7.85),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.69 | $14.45B | |
| 3.67 | $12.39B | |
| 14.12 | $12.41B | |
| 1.63 | $14.00B | |
| 49.57 | $13.62B | |
| 3.66 | $15.32B | |
| 43.53 | $10.34B | |
| 39.46 | $8.98B | |
| 7.56 | $19.18B | |
| 7.85 | $13.92B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tanvex BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tanvex BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Tanvex BioPharma, Inc.'s Current Ratio?
How is the Current Ratio calculated for Tanvex BioPharma, Inc. (6541.TW)?
What is the highest Current Ratio for Tanvex BioPharma, Inc. (6541.TW)?
What is the 3-year average Current Ratio for Tanvex BioPharma, Inc. (6541.TW)?
What is the 5-year average Current Ratio for Tanvex BioPharma, Inc. (6541.TW)?
How does the current Current Ratio for Tanvex BioPharma, Inc. (6541.TW) compare to its historical average?